Omeprazole treatment for prophylaxis of gastrointestinal bleeding and gastroesophagic reflux in critically ill children

Trial Profile

Omeprazole treatment for prophylaxis of gastrointestinal bleeding and gastroesophagic reflux in critically ill children

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2012

At a glance

  • Drugs Omeprazole (Primary) ; Ranitidine
  • Indications Gastro-oesophageal reflux; Gastrointestinal haemorrhage
  • Focus Therapeutic Use
  • Acronyms OmeprazolOM1
  • Most Recent Events

    • 17 Mar 2012 Status changed from active, no longer recruiting to recruiting as reported by European Clinical Trials Database.
    • 25 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top